Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00965601 · ClinicalTrials.gov registry record · Phase 4

A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia

A Phase 4 study of Fibromyalgia, sponsored by Indiana University.

Completed
Registry status
Phase 4
Development phase
30
Enrollment target
1
Study location

NCT00965601: Completed Phase 4 study of Fibromyalgia, sponsored by Indiana University.

NCT00965601 is a Phase 4 study of Fibromyalgia that has completed, run by Indiana University. The registered enrollment target is 30 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00965601, a Phase 4 study of Fibromyalgia, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 4
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators are doing this study to better understand the role of the central nervous system in processing painful stimuli in patients with fibromyalgia. Specifically, the investigators would like to know whether the central nervous system processing of painful stimuli changes with time and with talk therapy. In addition, the investigators are investigating how changes in your fibromyalgia symptoms may affect certain markers or proteins in your blood.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy

Study Locations (1)

Indiana

  • National Institute of Fitness and Sport; IUPUI Campus - Indianapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2008-07
Est. Completion 2009-08
Phase Phase 4
Indiana University

890 total trials

What the finished NCT00965601 record still lists

NCT00965601 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (83% lower).

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy is the first listed.

NCT00965601 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT00965601 about?

NCT00965601 is a clinical study titled "A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia". The investigators are doing this study to better understand the role of the central nervous system in processing painful stimuli in patients with fibromyalgia. Specifically, the investigators would like to know whether the central nervous system processing of painful stimuli changes with time and wi...

What is the current status of trial NCT00965601?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-07. Estimated completion is 2009-08.

What conditions does trial NCT00965601 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT00965601?

The interventions under investigation include: Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00965601?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00965601 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00965601's enrollment target sits among peer trials

30 60th of 76 higher than 16 of 76 other Fibromyalgia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00965601, the US trial registry maintained by the National Library of Medicine. NCT00965601 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.